Clinical trials are a necessary step in improving the treatment of ovarian cancer. Read some interesting quotes from professionals and national institutes about clinical trial importance.
"The more people that participate in clinical trials, the faster we can answer the critical research questions that will lead us to better treatment and prevention options for all cancers."
– Cancer Clinical Trials: A Resource Guide for Outreach, Education, and Advocacy, National Cancer Institute.
"Well-designed, well-run clinical trials are the only way to determine the true effectiveness of a promising new agent or intervention being investigated"
– Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"Clinical trials are sponsored by both government and private organizations including the National Cancer Institute (NCI) and pharmaceutical companies"
"Preliminary eligibility can be evaluated over the phone, and appointments with the clinical trial team can be scheduled if the person decides to proceed"
– Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"The enormous strides made in treating childhood cancer are the direct result of clinical trials. More than 60 percent of children with cancer participate in clinical trials, yet only 3 percent of adults with cancer do"
- Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"The NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged."
– National Comprehensive Cancer Network Guidelines for Ovarian Cancer, 2011.
"The NCCN panel encourages participation in ongoing clinical trials that are further investigating the role of anti-angiogenesis agents in the treatment of ovarian cancer, both in the upfront and recurrence settings."
– National Comprehensive Cancer Network Guidelines for Ovarian Cancer, 2011.
"During the informed consent process, you learn important information about the clinical trial that can help you decide whether to take part"
– Taking Part in Cancer Treatment Research Studies by the National Cancer Institute
"Enrollment in cancer trials among people under age18 is nearly 50 percent, which is far better than enrollment of adults with cancer. Partly because of this successful enrollment, childhood cancer survival rates have been increasing over the past several decades. A 50 percent enrollment rate for adult cancer clinical trials would give a huge boost to research efforts and potentially speed many new treatments to patients fighting cancer."
– Clinical Trials Awareness – National Cancer Institute website.
– Cancer Clinical Trials: A Resource Guide for Outreach, Education, and Advocacy, National Cancer Institute.
"Well-designed, well-run clinical trials are the only way to determine the true effectiveness of a promising new agent or intervention being investigated"
– Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"Clinical trials are sponsored by both government and private organizations including the National Cancer Institute (NCI) and pharmaceutical companies"
"Preliminary eligibility can be evaluated over the phone, and appointments with the clinical trial team can be scheduled if the person decides to proceed"
– Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"The enormous strides made in treating childhood cancer are the direct result of clinical trials. More than 60 percent of children with cancer participate in clinical trials, yet only 3 percent of adults with cancer do"
- Cancer Clinical Trials: The In-Depth Program, National Cancer Institute.
"The NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged."
– National Comprehensive Cancer Network Guidelines for Ovarian Cancer, 2011.
"The NCCN panel encourages participation in ongoing clinical trials that are further investigating the role of anti-angiogenesis agents in the treatment of ovarian cancer, both in the upfront and recurrence settings."
– National Comprehensive Cancer Network Guidelines for Ovarian Cancer, 2011.
"During the informed consent process, you learn important information about the clinical trial that can help you decide whether to take part"
– Taking Part in Cancer Treatment Research Studies by the National Cancer Institute
"Enrollment in cancer trials among people under age18 is nearly 50 percent, which is far better than enrollment of adults with cancer. Partly because of this successful enrollment, childhood cancer survival rates have been increasing over the past several decades. A 50 percent enrollment rate for adult cancer clinical trials would give a huge boost to research efforts and potentially speed many new treatments to patients fighting cancer."
– Clinical Trials Awareness – National Cancer Institute website.
